查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1789378

HSV 检测市场：按 HSV 类型、检体类型、年龄组、应用、最终用户和地区划分

HSV Testing Market, By HSV Type, By Type, By Sample Type, By Age Group, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年 HSV 检测市场价值估计为 6.424 亿美元，预计到 2032 年将达到 9.723 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.1%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 6.424亿美元
效能数据 2020-2024 预测期 2025-2032
预测期：2025-2032年 6.10% 2032年预测 9.723亿美元

全球HSV检测市场是诊断检测产业的重要组成部分，专注于检测和鑑定影响全球数百万人的单纯疱疹病毒感染。 HSV检测涵盖多种诊断方法，包括基于PCR的检测、抗原检测、基于抗体的血清学检测和病毒培养技术，每种方法都旨在识别HSV-1和HSV-2感染，其灵敏度和特异性各不相同。

由于人们对性行为感染认识的不断提高、全球疱疹感染疾病的盛行率不断上升以及对早期诊断和治疗性介入的日益重视，市场的重要性正在显着扩大。医疗保健提供者、临床实验室和就地检验机构构成了推动 HSV 检测解决方案需求的主要最终用户。市场格局的特点是技术的不断进步，例如快速诊断测试、准确性更高的分子诊断以及可提高工作流程效率的自动化测试平台的开发。此外，数位健康解决方案和远端医疗平台的整合为提高 HSV 检测的可近性创造了新途径，特别是在偏远和服务不足的地区。市场发展受到监管机构对新检测方法的核准、医疗保健支出的增加以及患者对保密和便捷检测方式的偏好日益增加的影响。

市场动态

全球HSV检测市场受多种关键驱动因素驱动，这些因素正在加速市场扩张，并促进各医疗机构的采用率。其中，最关键的驱动因素是全球单纯疱疹病毒感染疾病的日益普及。世界卫生组织估计，全球50岁以下人口中超过37亿人感染疾病HSV-1，15-49岁人群中4.91亿人感染疾病HSV-2，这导致对精准诊断解决方案的需求庞大。

分子诊断技术进步，尤其是即时PCR和次世代定序技术，一直是关键的成长驱动力，与传统检测方法相比，这些技术具有更高的灵敏度、特异性和快速的周转时间。性行为感染传染病宣导活动的不断加强以及人们对预防保健日益增长的兴趣，进一步刺激了市场需求。然而，市场也面临着许多限制因素，例如先进分子诊断设备和检测程序的高昂成本，限制了它们在资源匮乏的医疗机构中的普及。此外，与单纯疱疹病毒（HSV）检测相关的社会污名化也构成了心理障碍，可能会阻碍人们寻求诊断服务，从而限制市场成长。监管的复杂性和新诊断方法的核准时间缓慢也给寻求创新解决方案的市场相关人员带来了挑战。儘管存在这些限制因素，但随着就地检验能力的提升、私密性和便捷性兼具的家用检测套组的日益普及，以及医疗基础设施日益完善的新兴市场的日益普及，巨大的商机正在机会。人工智慧和机器学习在诊断平台中的整合为提高准确性和自动解释结果提供了机会，而诊断公司和远端医疗平台之间的合作则创造了新的分销管道，并改善了服务不足人群的检测机会。

本次调查的主要特点

  • 本报告对全球 HSV 检测市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%），以 2024 年为基准年。
  • 它还强调了各个领域的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
  • 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数概述了全球 HSV 测试市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球 HSV 测试市场报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过全球 HSV 测试市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章：调查目标和先决条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章：市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 抑制因素
  • 机会
  • 影响分析
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业趋势

4. 2020-2032 年全球 HSV 检测市场（按 HSV 类型划分）（百万美元）

  • 介绍
  • HSV-2检测
  • HSV-1检测
  • HSV类型未指定/组合测试

5. 全球 HSV 检测市场（按类型），2020 年至 2032 年

  • 介绍
  • 直接检测或培养测试（病毒培养）
  • 分子检测（PCR、TMA、NAAT等）
  • 血清学检测（如抗体检测）
  • 快速抗原检测（层析法）
  • 其他（产前筛检小组、居家采集套件包等）

6. 全球 HSV 检测市场（依样本类型），2020-2032 年

  • 介绍
  • 血液/血清/血浆
  • 水痘拭子/体液
  • 溃疡/焦痂拭子
  • 脑脊髓液（CSF）
  • 其他体液（如支气管肺泡灌洗液）

7. 2020-2032 年全球 HSV 检测市场（按年龄组别划分）

  • 介绍
  • 婴儿和新生儿
  • 婴儿
  • 成人
  • 老年人

8. 全球 HSV 检测市场（按应用划分），2020 年至 2032 年

  • 介绍
  • 临床疾病诊断
  • 流行病学研究（筛检）
  • 监控与监测
  • 其他的

9. 全球 HSV 检测市场（按最终用户划分），2020 年至 2032 年

  • 介绍
  • 医院
  • 临床诊断实验室
  • 居家照护
  • 照护现场环境
  • 血库和血浆采集中心
  • 其他（研究和学术机构）

10. 2020 年至 2032 年全球 HSV 检测市场（按地区划分）价值

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 东南亚国协
    • 其他亚太地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东地区
  • 非洲
    • 南非
    • 北非
    • 中部非洲

第十一章竞争格局

  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • BioMerieux
  • Thermo Fisher Scientific
  • Hologic Inc.
  • BD（Becton Dickinson）
  • Cepheid
  • Quidel Corporation
  • DiaSorin
  • PerkinElmer
  • Beckman Coulter
  • Agilent Technologies
  • Sysmex Corporation
  • Ortho Clinical Diagnostics

第 12 章分析师建议

  • 机会
  • 一致的机会地图

第十三章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8344

HSV Testing Market is estimated to be valued at USD 642.4 Mn in 2025 and is expected to reach USD 972.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 642.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.10% 2032 Value Projection: USD 972.3 Mn

The global HSV testing market represents a critical segment within the broader diagnostic testing industry, focusing on the detection and identification of Herpes Simplex Virus infections that affect millions of individuals worldwide. HSV testing encompasses various diagnostic methodologies including PCR-based assays, antigen detection tests, antibody-based serological tests, and viral culture techniques, each designed to identify HSV-1 and HSV-2 infections with varying degrees of sensitivity and specificity.

The market's significance has grown substantially, due to increasing awareness about sexually transmitted infections, rising prevalence of herpes infections globally, and the growing emphasis on early diagnosis and treatment intervention. Healthcare providers, clinical laboratories, and point-of-care testing facilities constitute the primary end-users driving demand for HSV testing solutions. The market landscape is characterized by continuous technological advancements, including the development of rapid diagnostic tests, molecular diagnostics with enhanced accuracy, and automated testing platforms that improve workflow efficiency. Additionally, the integration of digital health solutions and telemedicine platforms has created new avenues for HSV testing accessibility, particularly in remote and underserved regions. The market's evolution is further influenced by regulatory approvals for novel testing methodologies, increasing healthcare expenditure, and growing patient preference for confidential and convenient testing options.

Market Dynamics

The global HSV testing market is propelled by several key drivers that collectively enhance market expansion and adoption rates across diverse healthcare settings. The primary driver stems from the escalating global prevalence of herpes simplex virus infections, with WHO estimates indicating that over 3.7 billion people under age 50 have HSV-1 infection and 491 million people aged 15-49 have HSV-2 infection worldwide, creating substantial demand for accurate diagnostic solutions.

Technological advancements in molecular diagnostics, particularly real-time PCR and next-generation sequencing techniques, serve as significant growth catalysts by offering superior sensitivity, specificity, and rapid turnaround times compared to traditional testing methods. Increasing awareness campaigns about sexually transmitted infections and growing emphasis on preventive healthcare measures further stimulate market demand. However, the market faces notable restraints including high costs associated with advanced molecular diagnostic equipment and testing procedures, which limit accessibility in resource-constrained healthcare settings. Additionally, social stigma associated with HSV testing creates psychological barriers that discourage individuals from seeking diagnostic services, potentially limiting market growth. Regulatory complexities and lengthy approval processes for new diagnostic products also pose challenges for market players seeking to introduce innovative solutions. Despite these constraints, significant opportunities emerge from expanding point-of-care testing capabilities, increasing adoption of home-based testing kits that offer privacy and convenience, and growing penetration in emerging markets with improving healthcare infrastructure. The integration of artificial intelligence and machine learning in diagnostic platforms presents opportunities for enhanced accuracy and automated result interpretation, while partnerships between diagnostic companies and telemedicine platforms create new distribution channels and improve testing accessibility in underserved populations.

Key features of the study

  • This report provides an in-depth analysis of the global HSV Testing market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global HSV testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, BioMerieux, Thermo Fisher Scientific, Hologic Inc., BD (Becton Dickinson), Cepheid, Quidel Corporation, DiaSorin, PerkinElmer, Beckman Coulter, Agilent Technologies, Sysmex Corporation, and Ortho Clinical Diagnostics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global HSV testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HSV testing market.

Market Segmentation

  • HSV Type Insights (Revenue, USD Mn, 2020 - 2032)
    • HSV-2 Testing
    • HSV-1 Testing
    • HSV Type-Unspecified/Combined Tests
  • Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Direct Detection or Culture Test (Viral Culture)
    • Molecular Test (PCR Tests, TMA Tests, NAATs etc.)
    • Serological Tests (Antibody Detection etc.)
    • Rapid Antigen Tests (Immunochromatographic)
    • Others (Prenatal Screening Panels and Home Collection Kits, etc.)
  • Sample Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Blood/Serum/Plasma
    • Vesicular Swab/Fluid
    • Ulcer/Crust Swab
    • Cerebrospinal Fluid (CSF)
    • Other Body Fluids (e.g., Bronchoalveolar Lavage)
  • Age Group Insights (Revenue, USD Mn, 2020 - 2032)
    • Infants and Neonates
    • Children
    • Adults
    • Elderly
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Clinical Disease Diagnosis
    • Epidemiological Studies (Screening)
    • Surveillance and Monitoring
    • Others
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals
    • Clinical Diagnostic Laboratories
    • Home Care Settings
    • Point-of-care Settings
    • Blood Banks and Plasma Collection Centers
    • Others (Research and Academic Institutes)
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Roche Diagnostics
    • Abbott Laboratories
    • Siemens Healthineers
    • BioMerieux
    • Thermo Fisher Scientific
    • Hologic Inc.
    • BD (Becton Dickinson)
    • Cepheid
    • Quidel Corporation
    • DiaSorin
    • PerkinElmer
    • Beckman Coulter
    • Agilent Technologies
    • Sysmex Corporation
    • Ortho Clinical Diagnostics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global HSV Testing Market, By HSV Type
    • Global HSV Testing Market, By Type
    • Global HSV Testing Market, By Sample Type
    • Global HSV Testing Market, By Age Group
    • Global HSV Testing Market, By Application
    • Global HSV Testing Market, By End User
    • Global HSV Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global HSV Testing Market, By HSV Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • HSV-2 Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • HSV-1 Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • HSV Type-Unspecified/Combined Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global HSV Testing Market, By Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Direct Detection or Culture Test (Viral Culture)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Molecular Test (PCR Tests, TMA Tests, NAATs etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Serological Tests (Antibody Detection etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Rapid Antigen Tests (Immunochromatographic)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others (Prenatal Screening Panels and Home Collection Kits, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global HSV Testing Market, By Sample Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Blood/Serum/Plasma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Vesicular Swab/Fluid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ulcer/Crust Swab
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Cerebrospinal Fluid (CSF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Body Fluids (e.g., Bronchoalveolar Lavage)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global HSV Testing Market, By Age Group, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Infants and Neonates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Children
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Elderly
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global HSV Testing Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Disease Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Epidemiological Studies (Screening)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Surveillance and Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global HSV Testing Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Clinical Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Point-of-care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Blood Banks and Plasma Collection Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others (Research and Academic Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global HSV Testing Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioMerieux
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD (Becton Dickinson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cepheid
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quidel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaSorin
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Beckman Coulter
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ortho Clinical Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us